Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glen B Baker

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 2, 2002
Human CYP3A4 and the metabolism of nefazodone and hydroxynefazodone by human liver microsomes and heterologously expressed enzymesSusan Rotzinger, Glen B Baker
Journal of Psychiatry & Neuroscience : JPN|April 3, 2003
Interactions between the cytochrome P450 system and the second-generation antipsychoticsTrevor I Prior, Glen B Baker
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|February 11, 2009
Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrinKathryn G Todd, Glen B Baker
Annals of Medicine|January 30, 2003
Stereochemistry and drug efficacy and development: relevance of chirality to antidepressant and antipsychotic drugsGlen B Baker, Trevor I Prior
Future Medicinal Chemistry|September 13, 2013
Glycine reuptake inhibition: a promising therapeutic strategy in the treatment of schizophrenia?Pierre S Chue, Glen B Baker
Current Topics in Medicinal Chemistry|December 13, 2012
Recent developments in the regulation of monoamine oxidase form and function: is the current model restricting our understanding of the breadth of contribution of monoamine oxidase to brain [dys]function?Darrell D Mousseau, Glen B Baker
British Journal of Pharmacology|September 29, 2004
Allosteric modulation of semicarbazide-sensitive amine oxidase activities in vitro by imidazoline receptor ligandsAndrew Holt, Barbara Wieland, Glen B Baker
Frontiers in Cellular Neuroscience|June 12, 2014
Allopregnanolone and neuroinflammation: a focus on multiple sclerosisFarshid Noorbakhsh, Glen B Baker, Christopher Power
Cellular and Molecular Neurobiology|March 31, 2004
Inhibitory effects of the monoamine oxidase inhibitor tranylcypromine on the cytochrome P450 enzymes CYP2C19, CYP2C9, and CYP2D6Mahnaz Salsali, Andrew Holt, Glen B Baker
Psychiatry and Clinical Psychopharmacology|May 20, 2024
Hikikomori: A Society-Bound Syndrome of Severe Social WithdrawalBin Dong, Daniel Li, Glen B Baker
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 2, 2002
Human CYP3A4 and the metabolism of nefazodone and hydroxynefazodone by human liver microsomes and heterologously expressed enzymesSusan Rotzinger, Glen B Baker
Journal of Psychiatry & Neuroscience : JPN|April 3, 2003
Interactions between the cytochrome P450 system and the second-generation antipsychoticsTrevor I Prior, Glen B Baker
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|February 11, 2009
Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrinKathryn G Todd, Glen B Baker
Annals of Medicine|January 30, 2003
Stereochemistry and drug efficacy and development: relevance of chirality to antidepressant and antipsychotic drugsGlen B Baker, Trevor I Prior
Future Medicinal Chemistry|September 13, 2013
Glycine reuptake inhibition: a promising therapeutic strategy in the treatment of schizophrenia?Pierre S Chue, Glen B Baker
Current Topics in Medicinal Chemistry|December 13, 2012
Recent developments in the regulation of monoamine oxidase form and function: is the current model restricting our understanding of the breadth of contribution of monoamine oxidase to brain [dys]function?Darrell D Mousseau, Glen B Baker
British Journal of Pharmacology|September 29, 2004
Allosteric modulation of semicarbazide-sensitive amine oxidase activities in vitro by imidazoline receptor ligandsAndrew Holt, Barbara Wieland, Glen B Baker
Frontiers in Cellular Neuroscience|June 12, 2014
Allopregnanolone and neuroinflammation: a focus on multiple sclerosisFarshid Noorbakhsh, Glen B Baker, Christopher Power
Cellular and Molecular Neurobiology|March 31, 2004
Inhibitory effects of the monoamine oxidase inhibitor tranylcypromine on the cytochrome P450 enzymes CYP2C19, CYP2C9, and CYP2D6Mahnaz Salsali, Andrew Holt, Glen B Baker
Psychiatry and Clinical Psychopharmacology|May 20, 2024
Hikikomori: A Society-Bound Syndrome of Severe Social WithdrawalBin Dong, Daniel Li, Glen B Baker
Pageof 14